CCL5 and Cirrhosis: In a previous study, Hu et al found that CCL5 is a reliable biomarker for predicting liver fibrosis and cirrhosis: the expression of CCL5 in serum and hepatic tissue first increased in CHB patients with ongoing liver injury and then significantly decreased in advanced liver cirrhosis patients.20